Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |